Skip to main content
×
Home
    • Aa
    • Aa

Part I. Analysis of data gaps pertaining to Salmonella enterica serotype Typhi infections in low and medium human development index countries, 1984–2005

  • J. A. CRUMP (a1), P. K. RAM (a1), S. K. GUPTA (a1), M. A. MILLER (a2) and E. D. MINTZ (a1)...
Abstract
SUMMARY

There are only 10 contemporary, population-based studies of typhoid fever that evaluate disease incidence using blood culture for confirmation of cases. Reported incidence ranged from 13 to 976/100 000 persons per year. These studies are likely to have been done preferentially in high- incidence sites which makes generalization of data difficult. Only five of these studies reported mortality. Of these the median (range) mortality was 0% (0–1·8%). Since study conditions usually involved enhanced clinical management of patients and the studies were not designed to evaluate mortality as an outcome, their usefulness for generalizing case-fatality rates is uncertain. No contemporary population-based studies reported rates of complications. Hospital-based typhoid fever studies reported median (range) complication rates of 2·8% (0·6–4·9%) for intestinal perforation and case-fatality rates of 2·0% (0–14·8%). Rates of complications other than intestinal perforation were not reported in contemporary hospital-based studies. Hospital-based studies capture information on the most severe illnesses among persons who have access to health-care services limiting their generalizability. Only two studies have informed the current understanding of typhoid fever age distribution curves. Extrapolation from population-based studies suggests that most typhoid fever occurs among young children in Asia. To reduce gaps in the current understanding of typhoid fever incidence, complications, and case-fatality rate, large population-based studies using blood culture confirmation of cases are needed in representative sites, especially in low and medium human development index countries outside Asia.

Copyright
Corresponding author
*Author for correspondence: J. A. Crump, MB, ChB, DTM&H, Medical Epidemiologist, Enteric Diseases Epidemiology Branch, National Center for Zoonotic, Vectorborne, and Enteric Diseases, Centers for Disease Control and Prevention, Atlanta, GA 30333, USA. (Email: jcrump@cdc.gov)
Linked references
Hide All

This list contains references from the content that can be linked to their source. For a full set of references and notes please see the PDF or HTML where available.

4. ME Reller , Sexual transmission of typhoid fever: a multistate outbreak among men who have sex with men. Clinical Infectious Diseases 2003; 37: 141144.

7. JA Crump , Estimating the incidence of typhoid fever and other febrile illnesses in developing countries. Emerging Infectious Diseases 2003; 9: 539544.

8. T Butler , Typhoid fever complicated by intestinal perforation: a persisting fatal disease requiring surgical management. Reviews of Infectious Diseases 1985; 7: 244256.

9. S Hosoglu , Risk factors for enteric perforation in patients with typhoid fever. American Journal of Epidemiology 2004; 160: 4650.

11. DB Huang , HL DuPont . Problem pathogens: extra-intestinal complications of Salmonella enterica serotype Typhi infection. Lancet Infectious Diseases 2005; 5: 341348.

12. JH Mermin , A massive outbreak of multidrug-resistant typhoid fever in Tajikistan associated with consumption of municipal water. Journal of Infectious Diseases 1999; 179: 14161422.

13. ETAM van den Bergh , Outcome in three groups of patients with typhoid fever in Indonesia between 1948 and 1990. Tropical Medicine and International Health 1999; 4: 211215.

14. A Sinha , Typhoid fever in children aged less than 5 years. Lancet 1999; 354: 734737.

15. WA Brooks , Bacteremic typhoid fever in an urban slum, Bangladesh. Emerging Infectious Diseases 2005; 11: 326329.

16. C Ferreccio , Benign bacteremia caused by Salmonella Typhi and Paratypi in children aged younger than 2 years. Journal of Pediatrics 1984; 104: 899900.

17.  TO Mulligan . Typhoid fever in young children. British Medical Journal 1971; 4: 665667.

19.  ZA Bhutta . Impact of age and drug resistance on mortality in typhoid fever. Archives of Diseases in Childhood 1996; 75: 214217.

20. T Butler , Patterns of morbidity and mortality in typhoid fever dependent on age and gender: review of 552 hospitalized patients with diarrhea. Reviews of Infectious Diseases 1991; 13: 8590.

23. SK Saha , Typhoid fever in Bangladesh: implications for vaccination policy. Pediatric Infectious Diseases 2001; 20: 521524.

27. IL Acharya , Prevention of typhoid fever in Nepal with the Vi capsular polysaccharide of Salmonella Typhi. New England Journal of Medicine 1987; 317: 11011104.

29. MM Levine , Duration of efficacy of Ty21a, attenuated Salmonella Typhi live oral vaccine. Vaccine 1999; 17 (Suppl. 2): S2227.

31. FY Lin , The efficacy of a Salmonella Typhi Vi conjugate vaccine in two-to-five-year-old children. New England Journal of Medicine 2001; 344: 12631269.

32. MN Lanh , Persistent efficacy of Vi conjugate vaccine against typhoid fever in young children. New England Journal of Medicine 2003; 349: 13901391.

33. L Bodhidatta , Control of typhoid fever in Bangkok, Thailand, by annual immunization of schoolchildren with parenteral typhoid vaccine. Reviews of Infectious Diseases 1987; 9: 841845.

34. A Gupta , Evaluation of community-based serologic screening for identification of chronic Salmonella Typhi carriers in Vietnam. International Journal of Infectious Diseases 2006; 10: 309314.

38. SP Luby , Risk factors for typhoid fever in an endemic setting, Karachi, Pakistan. Epidemiology and Infection 1998; 120: 129138.

39. AM Vollaard , Risk factors for typhoid and paratyphoid fever in Jakarta, Indonesia. Journal of the American Medical Association 2004; 291: 26072615.

42. J Wain , Quantitation of bacteria in bone marrow from patients with typhoid fever: relationship between counts and clinical features. Journal of Clinical Microbiology 2001; 39: 15711576.

43. JA Crump , Reevaluating fluoroquinolone breakpoints for Salmonella enterica serotype Typhi and for non-Typhi salmonellae. Clinical Infectious Diseases 2003; 37: 7581.

44. SJ Olsen , Evaluation of rapid diagnostic tests for typhoid fever. Journal of Clinical Microbiology 2004; 42: 18851889.

46. KP Klugman , Immunogenicity, efficacy, and serological correlate of protection of Salmonella Typhi Vi capsular polysaccharide vaccine three years after immunization. Vaccine 1996; 14: 435438.

47. CH Simanjuntak , Oral immunisation against typhoid fever in Indonesia with Ty21a vaccine. Lancet 1991; 338: 10551059.

50. RE Black , Efficacy of one or two doses of Ty21a Salmonella Typhi vaccine in enteric-coated capsules in a controlled field trial. Vaccine 1990; 8: 8184.

52. MH Wahdan , A controlled field trial of live Salmonella Typhi strain Ty 21a oral vaccine against typhoid: three-year results. Journal of Infectious Diseases 1982; 145: 292295.

64. ME Ellis , A Moosa , V Hillier . A review of typhoid fever in South African black children. Postgraduate Medical Journal 1990; 66: 10321036.

65.  JM Topley . Mild typhoid fever. Archives of Diseases in Childhood 1986; 61: 164167.

73. ZA Bhutta , Multidrug-resistant typhoid in children: presentation and clinical features. Review of Infectious Diseases 1991; 13: 832836.

75. SS Islam , NS Shahid . Morbidity and mortality in a diarrhoeal diseases hospital in Bangladesh. Transactions of the Royal Society of Tropical Medicine and Hygiene 1986; 80: 748752.

79. R Rasaily , Multi-drug resistant typhoid fever in hospitalized children: clinical, bacteriological and epidemiological profiles. European Journal of Epidemiology 1994; 10: 4146.

84. F Kizilcan , Complications of typhoid fever requiring laparotomy during childhood. Journal of Pediatric Surgery 1993; 28: 14901493.

Recommend this journal

Email your librarian or administrator to recommend adding this journal to your organisation's collection.

Epidemiology & Infection
  • ISSN: 0950-2688
  • EISSN: 1469-4409
  • URL: /core/journals/epidemiology-and-infection
Please enter your name
Please enter a valid email address
Who would you like to send this to? *
×